Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for AUPH
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- BarryC: $AUPH Worth Watching again....
- woodman: @BarryC $AUPH - I'm still holding some of this.
- BarryC: I have an eye on $AUPH
- woodman: @BarryC $AUPH - I have smallish position in this. It's been on a nice path since beginning when it gapped up. Talk about it being bought by Big Pharma continues. It reports 5/4 bmo.
- woodman: @BarryC $AUPH - the knock on $AUPH is management which is generally considered poor and accused of enriching itself.
- BarryC: $AUPH Worth Watching
- BarryC: #FWIW, Here is my current watchlist: $ADBE, $AGI, $ARRY, $ASAN, $AUPH, $AXON, $BOTZ (Sector), $CRSR, $CXM, $DASH, $DM, $EDU, $FLYW, $FGNU, $FSLY, $FSM, $GDX, $GLD, $HUBS, $IGV (Sector), $INMD, $IQNQ, $ITA (Sector), $LRCX, $MGM, $MSFT, $NEM, $NET, $NU, $NVDA, $NVTS, $ONON, $OR, $PD, $PEGA, $PYXS, $SE, $SPOT, $TCOM, $TECK, $TGTX, $TSCO, $TGX, $WPM, $Z
- BarryC: $AUPH Worth Watching
- woodman: $AUPH - I lost track of this biotech which has broken out. As a result, my position is still small. It has an approved drug (Lupkynis) for Lupus Nephritis (for people with kidney disease caused by Lupus which is an auto-immune disease) which is now in post-marketing studies. It had been approved with a black box relating to things that can happen when on immunosuppressants . Back in February, it seemed - and I guess still seems - like a good story for the rollout of its approved drug. I saw target price of $15 back then, for whatever that's worth. I haven't done enough research on this of late but could be a good one to ride higher. Just an idea.
- Justhanging48: For what it's worth, my best 5 performers today (on a very bad day) were: $COGT, $XFOR, $ORMP, $AUPH and $CCL (image that one!).
- Docoof: @Justhanging48 $COGT $XFOR $ORMP $AUPH $CCL I continue to hold $WFRD and have been adding on pullbacks. Did you take profits and sell? I’m asking because I’m interested in how another member has been trading it and I know you did have a profitable position. Thanks in advance. (My other motive for asking is that it did not show up in your 5 best performers today.)
- Justhanging48: @Docoof $COGT $XFOR $ORMP $AUPH $CCL $WFRD With $WFRD bought on 12/16 at $45.43 with a target of $50. On 12/20 took partials at $48.02 and the next day sold the rest at $49.96. Haven't been back to it since then.
- Docoof: @Justhanging48 $COGT $XFOR $ORMP $AUPH $CCL $WFRD Thank you for the response. Forum responses have been one of my primary resources for learning how to trade. So I really appreciate it.
- woodman: $AUPH continues to gap-fill. Added this to my #biotech arsenal yesterday on news of patent settlement and M&A speculation.
- woodman: $AUPH RBC: "Announced settlement with Sun Pharma; PT increase to $11.00." Cantor:" IPR Settlement Is A Big Win to Kick Off 2023"
- steve71: $AUPH $IBB $XBI Biotech charts continue to look like Biden/Harris polling numbers but Aurinia has been strong. Aurinia may be a hedge fund plaything, as swarms of twits bet on buyout potential. Their product Lupkynis is approved for lupus nephritis and is the real deal. Competition is GSK's Benlysta, FDA approved one month before. Further competition is possible but a year or two from approval, if ever. People seem to bid this up into Friday afternoon, looking for weekend acquisition news. I have been selling Friday afternoon, then rebuying M, T, W.
- Motorman: @steve71 $AUPH $IBB $XBI Holding a partial $AUPH after selling the pop on the news last time. Good plan.
- Motorman: @woodman $CLDX $AUPH if memory serves me well, you brought this to forum around $6 or so. Thanks
- woodman: @Motorman $CLDX $AUPH - AUPH? Sheesh, I can't recall. Looking at my old notes, that could be right. I do recall mentioning it and its work on voclosporin for Lupus nephritis.
- woodman: @Motorman $CLDX $AUPH - I have another spec biotech that I'm holding. Spec is an understatement for it. I can post if interested but I warn you, it's very risky.
- Motorman: $AUPH Above 2019 high.
- bRobert: @Motorman $AUPH Lost track of this one $26 flag target WEEKLY may support $30
- AlexH: $AUPH does anyone knows what's going on with $AUPH, i see no news
- mopick: @AlexH $AUPH, takeover speculation....
- Motorman: @mopick $AUPH Great, I thought it was a delayed reaction to government contract announced yesterday.
- AlexH: @mopick $AUPH how or where did you get this from please? links?
- gtr89: @Motorman $AUPH I’ve held this stock as a spec for some time. Not the first time in the past year it has jumped big on a buy out rumor. I hope it’s true this time.
- mopick: @AlexH $AUPH, According to thestreet.com, "AUPH speculators are citing a cancelled conference and a change in jobs listing as support for a potential take-over deal."
- rjw225: $AUTL $AUPH Anybody in these stocks? I am in them sort of long term but both have catalysts coming up.
- rjw225: $DVAX and $AUPH -- anybody in these biotechs? Any opinions from more experienced players will be appreciated.
- Motorman: @rjw225 $DVAX $AUPH Yes in $AUPH, cut position in half at 12 to contain losses, then it went to 10, now it reversed. Up against 200 day now from underside and 50 week.
- steve71: $SPG Down 3%, a good opportunity to add to Simon Property group. Earnings yesterday as expected. Malls seeing more traffic. Vacancies filling and Simon has some pricing power. New acquisitions were cherry picked from weaker players in the last year. Simon cut the dividend last year but that is very likely to be restored as rents go up. Currently 4.24% plus nice capital appreciation. Long and adding. $AUPH $MYOV A pair of de-risked biotechs having a day. Long and adding.
- Motorman: $AUPH @bRobert Looks like a reversal, weekly hovering above 20 and 50 week, about to cross. Low volume though
- bRobert: @Motorman $AUPH Lot of speed bumps to top of range then the potential opens Easier ways to make a living It works but SHOP was easier ;) Many good pullback bounces MANY
- Motorman: @bRobert $AUPH Saw you post on $SHOP in pre, added LT and traded half for some $$$
- bRobert: @Motorman $AUPH $SHOP EASIER than $AUPH Hold a spec size and FOCUS other places until it is ready
- Motorman: $AUPH Nice bounce off 20 day, weekly sideways consolidation for 9 months
- Motorman: $AUPH break out, PB, Bounce.
- mopick: $AUPH, watching this one, a fave of the Rev. 2 major catalysts on the horizon within the next 2 months; new treatment for Lupus & 'Voclosporin" new, revolutionary treatment for dry eye syndrome. Both predicted to be approved by the end of the year.
- traderbren: $AUPH - pushing above the 50 dma...
- traderbren: $AUPH -- pushing up against 50 dma and 20 dma -- see if it breaks above $16.16 with some follow-through for a potential trade. NP
- bRobert: $AUPH ooze out $BX flag trigger $57.5 $KKR flag $30/$34 Long term fan of both
- WebstreamDyn: @DAN Can you give me your thoughts on $AUPH? I have a couple shares at 17.66. The Bollinger Bands loook sort of crazy. Not sure what to expect.
- DAN: @WebstreamDyn $AUPH It looks tired to me. If I owned any (and I don't), I'd either sell it, or keep a stop just below $18.00
- WebstreamDyn: @DAN - I watched your "Turning Patterns into Profits" video this morning and things are making a lot more sense to me. I sold out of $AUPH for a nice profit. I see why I got stopped out on $INMD today. The 50-MA is way below around 39.73 and I should have grabbed the 45 price early this morning. I am only holding one stock - $SYRS which I bought at a good entry (5.09), but will probably close out today. Then start after the holidays to look at patterns with a whole new prespective. Thanks again!!
- DAN: @WebstreamDyn $AUPH $INMD $SYRS So glad you are getting the hang of it. Self-awareness is super important. When you know what you're doing wrong, you can fix it. But when things are just going wrong and you're confused, you have no idea what to fix.
- WebstreamDyn: @justinm89 #OT I am pretty new as well. When i looked backed at my trades they mirror exactly what you are seeing. Buying at the wrong entry has been an issue for me. Also, I have find biotech stocks have wild swings (like $INMD and $AUPH). If buy them at a poor entry or try a tight stop I get stopped out everytime. I am still in the learning mode, esepciaily when I do bigger buys.
- WebstreamDyn: $INMD $AUPH $SYRS - been out most of the day and see all three were up, only $BBBY is down. For the first time I tried a cheapy stock $YAYO, the stock is down but I am up because i bought it at 1.43 (1000 shares). I have never tried something this cheap before. Thinking of it as a few days swing trade and see what happens. I have a tight stop on it.
- WebstreamDyn: $AUPH - finally climbing nicely. Debating if I should add to my position
- WebstreamDyn: $AUPH finally broke the 20.00 mark!! I hope it holds.
- issues: @Herb $MIRM Thank you for this addition to my list of the best biotechs: $AUPH $DCPH $ISEE $JNCE $HZNP $AMRN $PFNX $AKBA... we hold AUPH ISEE and others not listed.
- WebstreamDyn: @champ @brett_anderson @Henry $LMPX $KIDS $INMD #Timing Thanks guys. Ya it is hard to swallow some days. I go from 2000+ up to -700 in the hole. Then watch ones do well I passed on. My only good trade left so far is $AUPH. I am still very inconsistant, up for a few days than down and give back all the dollars I had gained.
- champ: @WebstreamDyn $LMPX $KIDS $INMD $AUPH #Timing --- It is always hard but investor's know all about the daily profit swings, the zig-zags, that is what investor's do and that is also what investor's expect to see daily. Just saying, this is how the markets work and it is Never going to change. I always expect to see my profits Zig-Zag, everyday, just like today. All swing trades, are all chess-moves, need to learn, to expect profit zig-zags. The #CopyCat-Traders, are mostly the ones who take the losses, in a market that is working. Just saying...#Good-Luck!
- WebstreamDyn: Even after the stock offering 2 days ago, $AUPH has been slowly improving.
- issues: @WebstreamDyn $AUPH Thank you for the reminder. I bought a very small position with the expectation of a drop. A significant drop to add.
- DrScience: $AUPH squirting to new high, squeezing some more shorts in the process.
- shoredriver: @DrScience $AUPH ...Priced follow on @15 last night....
- PhilHarmonic: @DrScience $AUPH Is it squirting and squeezing or squeezing and squirting. I sww the volatility squeeze but what kind of sqirting is it?
- DrScience: @PhilHarmonic $AUPH 😁 the kind that makes money!
- issues: Biotech has gone from IBD group 4 to group 3 and today it's group 2! It constantly changes stocks in this very aggressive group. They are different again today. I look at first the ones under "accumulation" then under "relative strength." So the symbols under accumulation are: $ACIU $AUPH $ISEE $ALLK $APLT $ARAV $ARDX $ARWR & $CORT. The percent increases for the past 10 days start with $AUPH up a mere 160%, then $ISEE at 50%, then $ALLK at 35% then $ARAV at 30% and $APLT at 25% and $AVDL at 25%. Although many of these are at a high, I bought a small number of shares anticipating a drop down where I can add to holdings. So today I bought the following: $ARVN $ISEE $AVDL $ARDX Yesterday I sold $FTSV too soon at $26 (now it's $35) and $ARQL for a great profit.
- WebstreamDyn: One I am watching closely and still in is $AUPH... it has great potential long term. Showing life today after everyone sold their shares from the big jump.
- Herb: @baronp0329 $AUPH Do you follow Jeff Cooper these days?
- Herb: @DavidM $AUPH There is no SEC (except to grease the skids for Goldman). . . . .
- jlutzkanin: @Herb $AUPH Looking at a double this morning
- phgruver: @Herb $AUPH There was probably an information leak, but a "leak" doesn't automatically equate to "insider information." It's pretty tough to prove. Just look back at Martha Stewart's case. She went to jail because she "probably lied" to the grand jury, not because of insider trading.
- baronp0329: @Herb $AUPH No. I don't follow Jeff Cooper. A friend follows him and sent me the tweet
- WebstreamDyn: Bought $AUPH when it dropped into the mid 15.50s... Crossing my fingers it makes a big run up today. You never know for sure with Biotechs.
- WebstreamDyn: Another question.... in ThinkorSwim I have noticed right after the market closes some huge stock buys or sells... why then? For example, today I saw a 348,000+ stock buy for $AUPH. Yesterday, I saw a 180,00 sell for $CLVS and another stock buy for 1,0000,000 shares of $PLUG. Why after the closing bell?
- Tango:
- champ: @WebstreamDyn $AUPH $CLVS $PLUG --- #Watch-and-Learn and start out small, real small --- You asked #why the moves after the close, it is all about the #News, There is individual stock news, plus sector News, like certain stocks in the retail sector are currently working. Plus there is also Market News. It you have entry timing on your stock because of positive news that is called entry-timing and if you also have Sector and Market timing, that can also help investor's and traders on their position-size. If you have all 3-timings, that would be a strong buy. (stock, sector and the markets) .......New investor's need to watch and learn before they enter the markets, especially if they have other Day commitments, another job.... or they will take losses.
- champ: @Tango $AUPH $CLVS $PLUG --- After hours trades are listed by size. During market hours you can see size, on the 1-minute bar but on high volume stocks, it is very hard but larger size is not as hard to spot. However, if you see volume, there is always a reason, check-out the news, if you have a news feed.
- WebstreamDyn: @Herb $KOD $ALLK See also $AUPH (post-market)
- Herb: $AUPH way up. https://www.marketwatch.com/story/aurinia-pharmaceuticals-surges-more-than-110-after-positive-trial-for-lupus-related-drug-2019-12-04?siteid=yhoof2&yptr=yahoo
- shoredriver: @Herb $AUPH ....you're buying?
- Herb: @shoredriver $AUPH No. Contemplating.
- gwenzee: @Herb $AUPH Did you contemplate too long. Up 115% AH. Hate it when that happens. NP
- WebstreamDyn: BIOs gone wild! $KOD, $RLMD, $AUPH, $ALLK and i missed them all while out of the office working. :-(
- Herb: @gwenzee $AUPH mind run over by hobgoblins.
- Herb: @WebstreamDyn $KOD $RLMD $AUPH $ALLK Was RLMD an ipo today?
- WebstreamDyn: @WebstreamDyn $KOD $RLMD $AUPH $ALLK BIOs I am watching.. $AMRN, $ARWR, $ASLN, $CLVS ....any other BIOs to watch? (Also, watching SMM tweets. :-) )
- WebstreamDyn: @Herb $KOD $RLMD $AUPH $ALLK This is all I know... >>> NEW YORK , Oct. 8, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (OTCQB: RLMDD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that the Company's common stock has been approved for listing on The Nasdaq Capital Market . Trading on Nasdaq is expected to begin on Thursday, October 10 , under the existing symbol, "RLMD." <<<
- gwenzee: @Herb $AUPH Back to the old drawing board. I'm still holding $INCY and bought $EDIT today. Would like to see these go up 40-45% in a day.
- baronp0329: Jeff Cooper @JeffCooperLive · 2h "someone bought $2million of calls on $AUPH this morning. traded from 8 to over 20 after hours. must be nice to be such a great trader :)
- PhilHarmonic: @baronp0329 $AUPH We all have had similar experience during our lifetimes. Your's will come if you stick with it.
- Reif99: @PhilHarmonic $AUPH I'm pretty sure I will never have the experience of buying $2 million worth of calls.
- PhilHarmonic: @Reif99 $AUPH You miss the point. $2 million might not be that much money for this buyer. The excitement is from the big after hours gain.
- DavidM: @baronp0329 $AUPH Seems there might be some SEC investigating to be done there :-)
- Motorman: @woodman $AUPH Weekly slow climb, daily phase 2
- issues: Looking over the IBD 50 I see some interesting choices among which is $HASI. I like the chart. Looks like a potential break out from a volume squeeze. NP Some other that look appetizing are $YETI $CORE $INCY $AUPH... and $AGEN
- Junior1:
- Vehid: @Junior1 $AUPH what would be the stop loss price?
- Junior1: $AUPH up 10.8% No news that I've found.
- woodman: $AUPH - I learned previously that this stock is the master of fakeouts.
- traderbren: $AUPH -- looking good. Long.
- Bridget: $AUPH is moving out of a squeeze
- woodman: @Bridget $AUPH - I've been flipping back to it repeatedly today, but didn't buy it. It's faked me out in the past.
- Junior1: @Bridget $AUPH I had a full position since $7.83. Sold half at 6.19 last month (not happy). Gonna hold the other 1/2 LT
- Junior1: @Bridget $XBI yes. $AUPH is looking constructive here. Phase 3 starting? Support rhrn @ 50dma and 20dma
- woodman: $AUPH - worth watching. It had a big pop/breakout, pullback to the breakout level, and now resting at that breakout level. I'm thinking there is the potential for a move back up (even though this hasn't really worked in the past with this stock).
- DAN: @woodman $AUPH Yeah, it's holding up pretty well. Looks like Phase 1 may be over!
| Stock Price | $8.97 |
| Change | -0.66% |
| Volume | 210,839 |
Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. Its focused on the development of its novel therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis.
Request Video of AUPHAlready a member? Sign in here.
Past Month
Leading Peers
-
$8.10 261.95%
-
$9.45 124.91%
-
$16.98 106.56%
Past Month
Lagging Peers
-
$9.73 %
-
$17.03 -115.10%
-
$35.42 -44.96%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!